D.E. Shaw & Co
DNA icon

D.E. Shaw & Co’s Ginkgo Bioworks DNA Stock Holding History

D.E. Shaw & Co’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-222,800
Closed -$1.85M – 4646
2025
Q4 		$1.85M Buy
222,800
+59,100
+36% +$636K ﹤0.01% 3117
2025
Q3 		$2.39M Buy
+163,700
New +$1.96M ﹤0.01% 2837
2025
Q1 		– Sell
-55,500
Closed -$545K – 4364
2024
Q4 		$545K Sell
55,500
-5,000
-8% -$42.9K ﹤0.01% 3568
2024
Q3 		$493K Buy
+60,500
New +$606K ﹤0.01% 3709

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return